Breakthrough T1D Request for Applications: Accelerating the Development of Combined CGM–Pump Devices
Funds research to advance integrated CGM–insulin pump devices that address technical and translational challenges in type 1 diabetes care.
Funder: Breakthrough T1D
Due Dates: September 2, 2026 (LOI) | November 4, 2026 (Full proposal)
Funding Amounts: Up to $900,000 total for up to 3 years; smaller budgets considered; 10% indirect costs for nonprofits, none for for-profit applicants.
Summary: Supports research and development of integrated CGM–insulin pump devices to overcome technical and translational barriers for type 1 diabetes management.
Description
This funding opportunity from Breakthrough T1D is designed to accelerate the development of integrated continuous glucose monitor (CGM) and insulin pump devices for type 1 diabetes (T1D) management. The program targets projects addressing technical, clinical, and translational challenges in creating combined devices, with the goal of simplifying diabetes care and improving outcomes. Proposals should focus on device integration, system reliability, manufacturing scalability, and the interaction between insulin delivery and glucose sensing. Collaborative, user-centered, and cross-sector projects are encouraged, as well as feasibility studies, clinical evaluations, and research that can de-risk development and support real-world adoption.
